The present invention discloses compounds of Formula (I): wherein the variables in Formula (I) are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula (I) in the prevention or treatment of HCV infection.
申请公布号
HK1217200(A1)
申请公布日期
2016.12.30
申请号
HK20160105249
申请日期
2016.05.09
申请人
F. HOFFMANN-LA ROCHE AG
发明人
BERTHEL, Steven Joseph;CHEN, Zhi;CHI, Feng;CHIN, Elbert;ERICKSON, Shawn David;GABRIEL, Stephen Deems;KOCER, Buelent;MERTZ, Eric;PLANCHER, Jean-Marc;WEIKERT, Robert J.
